Biosenic【0R55】銘柄情報

Biosenic (0R55) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

3.845

( - )

買値

3.75

売値

3.94

出来高

0.00

0.00 日の範囲 0.00

3.845 52 週間の範囲 3.845

時価総額

2.51B

前日終値

3.845

始値

時刻

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

1,191,889 €

発行済株式数

652,862,279

配当利回り

PER

-0.22

1 株当たり利益 (EPS)

-0.01

歳入

-2.39M

純利益

-4M

BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intr... BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intravenous drug to treat autoimmune diseases. In addition, the company develops 4P004v which is in Phase I clinical trial for veterinary use. BioSenic S.A. is headquartered in Saintes, Belgium. 詳細を表示

セクター

業界

ウェブサイト

www.biosenic.com

本社

Saintes, Belgium

設立

Biosenic is listed in the sector of the ロンドン証券取引所 with ticker 0R55. The last closing price for Biosenic was 3.85 €. Over the last year, Biosenic shares have traded in a share price range of 3.845 € to 3.845 €.

Biosenic currently has 652,862,279 shares in issue. The market capitalisation of Biosenic is 2.51 € billion. Biosenic has a price to earnings ratio (PE ratio) of -0.22.

BioSenic fait le point sur ses activités du troisième trimestre 2024

BioSenic fait le point sur ses activités du troisième trimestre 2024 BioSenic fait le point sur ses activités du troisième trimestre 2024 BioSenic...

BioSenic provides third quarter 2024 Business Update

BioSenic provides third quarter 2024 Business Update BioSenic provides third quarter 2024 Business Update BioSenic is actively seeking one or more...

BioSenic S.A. : Transparency notification received from ABO Infinium Americas OpCo LTD.

BioSenic S.A. : Transparency notification received from ABO Infinium Americas OpCo LTD. REGULATED INFORMATION Article 14 of the Law of 2 May...

BioSenic S.A. : Notification de transparence reçue de la part de ABO Infinium Americas OpCo LTD.

BioSenic S.A. : Notification de transparence reçue de la part de ABO Infinium Americas OpCo LTD. INFORMATION REGLEMENTEE Article 14 de la loi...

BioSenic annonce démarrer la recherche de nouveaux actifs, la sécurisation de son financement pour les prochains mois par le biais d'un avenant à son contrat d'obligations convertibles, une modification de la composition de son conseil

BioSenic annonce démarrer la recherche de nouveaux actifs, la sécurisation de son financement pour les prochains mois par le biais d'un...

BioSenic announces that it has started to look for new assets, the securing of its financing for the coming months by means of an amendment to its convertible bond contract, a change to the composition of its board of directors

BioSenic announces that it has started to look for new assets, the securing of its financing for the coming months by means of an amendment to its...

期間 †	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	3.845	3.845	3.845	139895	3.845	DE
52	3.845	3.845	3.845	402632	3.845	DE
156	3.845	3.845	3.845	484556	3.845	DE
260	3.845	3.845	3.845	283509	3.845	DE